Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 2.950
+0.060 (2.08%)
Apr 24, 2026, 5:29 PM CET
Sprint Bioscience AB Earnings Call Transcripts
Fiscal Year 2025
-
A 16-year innovation-driven company specializes in early-stage drug discovery, focusing on oncology and leveraging fragment-based design. It maintains a broad, flexible portfolio, pursues licensing, spinouts, and strategic collaborations, and is recognized for its expertise and adaptable business model.